These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 39040013)

  • 1. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
    Sasidharan Pillai S; Gagnon CA; Foster C; Ashraf AP
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2709-2719. PubMed ID: 39040013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
    Olteanu G; Ciucă-Pană MA; Busnatu ȘS; Lupuliasa D; Neacșu SM; Mititelu M; Musuc AM; Ioniță-Mîndrican CB; Boroghină SC
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic networks of the human gut microbiota.
    Selber-Hnatiw S; Sultana T; Tse W; Abdollahi N; Abdullah S; Al Rahbani J; Alazar D; Alrumhein NJ; Aprikian S; Arshad R; Azuelos JD; Bernadotte D; Beswick N; Chazbey H; Church K; Ciubotaru E; D'Amato L; Del Corpo T; Deng J; Di Giulio BL; Diveeva D; Elahie E; Frank JGM; Furze E; Garner R; Gibbs V; Goldberg-Hall R; Goldman CJ; Goltsios FF; Gorjipour K; Grant T; Greco B; Guliyev N; Habrich A; Hyland H; Ibrahim N; Iozzo T; Jawaheer-Fenaoui A; Jaworski JJ; Jhajj MK; Jones J; Joyette R; Kaudeer S; Kelley S; Kiani S; Koayes M; Kpata AJAL; Maingot S; Martin S; Mathers K; McCullogh S; McNamara K; Mendonca J; Mohammad K; Momtaz SA; Navaratnarajah T; Nguyen-Duong K; Omran M; Ortiz A; Patel A; Paul-Cole K; Plaisir PA; Porras Marroquin JA; Prevost A; Quach A; Rafal AJ; Ramsarun R; Rhnima S; Rili L; Safir N; Samson E; Sandiford RR; Secondi S; Shahid S; Shahroozi M; Sidibé F; Smith M; Sreng Flores AM; Suarez Ybarra A; Sénéchal R; Taifour T; Tang L; Trapid A; Tremblay Potvin M; Wainberg J; Wang DN; Weissenberg M; White A; Wilkinson G; Williams B; Wilson JR; Zoppi J; Zouboulakis K; Gamberi C
    Microbiology (Reading); 2020 Feb; 166(2):96-119. PubMed ID: 31799915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency.
    Kumar Singh A; Cabral C; Kumar R; Ganguly R; Kumar Rana H; Gupta A; Rosaria Lauro M; Carbone C; Reis F; Pandey AK
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiota and obesity].
    Karney A
    Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults.
    Lippert K; Kedenko L; Antonielli L; Kedenko I; Gemeier C; Leitner M; Kautzky-Willer A; Paulweber B; Hackl E
    Benef Microbes; 2017 Aug; 8(4):545-556. PubMed ID: 28701081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.
    Debédat J; Clément K; Aron-Wisnewsky J
    Curr Obes Rep; 2019 Sep; 8(3):229-242. PubMed ID: 31197613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.
    Marotz CA; Zarrinpar A
    Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding how pre- and probiotics affect the gut microbiome and metabolic health.
    Bock PM; Martins AF; Schaan BD
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E89-E102. PubMed ID: 38809510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.